Sangamo Therapeutics, Inc. Profile Avatar - Palmy Investing

Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The…

Biotechnology
US, Brisbane California [HQ]

News

Theses · Events · Sentiments
End of SGMO's Analysis
CIK: 1001233 CUSIP: 800677106 ISIN: US8006771062 LEI: - UEI: -
Secondary Listings